BRENDA GRZENIA: Open Payments
NPI 1376317388 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$261 in 9 payments from 7 companies in 2025. Trend: 2023 $486 · 2024 $1,053 · 2025 $261
Food & beverage: $217Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Celltrion USA Inc. | 1 | $41 |
| BeiGene USA, Inc. | 1 | $38 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: ENHERTU, VEGZELMA, BRUKINSA, SCEMBLIX, ZEPZELCA, KISQALI, ZEJULA, JEMPERLI.
Industry payments across IL — which companies pay providers there.
